Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

443
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
443
Ligand Binding Sites02:40

Ligand Binding Sites

12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Quantum-machine-assisted drug discovery.

npj drug discovery·2026
Same author

Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

Nature nanotechnology·2026
Same author

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph.

BMC bioinformatics·2026
Same author

Establishment of a Spectral Detection Method for Microfluoroplastics: Revealing Widespread Pollution and Conventional Digestion-Induced Underestimation.

Environmental science & technology·2026
Same author

Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan.

Bone marrow transplantation·2026
Same author

The Impact of Female-To-Male Allogeneic Hematopoietic Cell Transplantation on Survival Outcomes Varies by Recipient Age.

Transplantation and cellular therapy·2026
Same journal

MetaboNet-Bench: A Multi-modal Benchmark for Glucose Forecasting in Type 1 Diabetes.

ArXiv·2026
Same journal

A Positron Range Correction with Texture Preservation Framework in PET Imaging.

ArXiv·2026
Same journal

Automated optimization of force field parameters against ensemble-averaged measurements with Bayesian Inference of Conformational Populations.

ArXiv·2026
Same journal

Droplet Fusion as a Relaxation Process: Comparison with Shape Recovery of Newtonian and Viscoelastic Droplets.

ArXiv·2026
Same journal

Ridge-filter crosstalk in conformal proton FLASH planning: dependence on beamlet pitch and iterative mitigation.

ArXiv·2026
Same journal

Electrochemical DNA Hairpin Sensors for Differentiating Small Molecule Intercalation from Minor Groove Binding.

ArXiv·2026
查看所有相关文章

相关实验视频

Updated: May 12, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.3K

DruGagent:多代理大型语言基于模型的推理,用于药物向相互作用预测.

Yoshitaka Inoue1,2, Tianci Song3, Xinling Wang4

  • 1Dept of Computer Science and Engineering, University of Minnesota, Minneapolis, MN, USA.

ArXiv
|April 29, 2025
PubMed
概括
此摘要是机器生成的。

DrugAgent是一个多代理大型语言模型系统,通过整合多种数据和透明推理,增强了药物向相互作用预测. 这种方法显著提高了药物发现应用的准确性和可解释性.

更多相关视频

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

相关实验视频

Last Updated: May 12, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.3K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

科学领域:

  • 计算生物学是一种计算生物学.
  • 人工智能在药物发现中的作用

背景情况:

  • 大型语言模型 (LLM) 提供类似人类的界面,但在需要多个视角的复杂场景中难以准确.
  • 现有的药物向相互作用 (DTI) 预测方法在解释性和处理生物系统复杂性方面面临挑战.

研究的目的:

  • 开发DrugAgent,一个多代理的LLM系统,以提高DTI预测的透明推理.
  • 提高DTI药物发现预测的一致性,可靠性和可解释性.

主要方法:

  • 实现了针对DTI领域量身定制的基于协调员的多代理架构.
  • 集成的特定领域的数据来源:机器学习预测,知识图表和文献证据.
  • 集成的思维链 (CoT) 和 ReAct (Reason+Act) 框架,以实现透明的 DTI 推理.

主要成果:

  • 与非推理多剂模型 (GPT-4o mini) 相比,DrugAgent在酶抑制剂数据集 (0.514对0.355) 上获得了45%的F1得分.
  • 除研究发现AI代理最具影响力,其次是KG和搜索代理.
  • 该系统为DTI预测提供了详细的,人类可解释的推理.

结论:

  • 药物代理提供了一个强大的多代理LLM框架,用于准确和可解释的DTI预测.
  • 多样化的数据源和推理框架的整合对于推进药物发现工具至关重要.
  • 透明的推理对于临床决策和生物医学应用中的监管合规性至关重要.